Literature DB >> 6267607

Immunochemical delineation of an oncofetal antigen on normal and simian virus 40-transformed human fetal melanocytes.

A C Morgan, D R Galloway, F C Jensen, B C Giovanella, R A Reisfeld.   

Abstract

Human melanoma cells of uveal origin shed 94,000- and 240,000-dalton glycoproteins in common with most melanoma cell lines of dermal origin. Normal human melanocytes derived from fetal uvea shed a 90,000-dalton glycoprotein that was found to be immunologically identical with the 94,000-dalton glycoprotein of melanoma cells. Expression of this 90,000-dalton molecule was confined to fetal cells of ectodermal origin. After simian virus 40 (SV40) transformation of human fetal melanocytes, there was an apparent increase in molecular size of this component to 94,000 daltons. In contrast, the 240,000-dalton glycoprotein was not synthesized or shed by uninfected or SV40-transformed fetal melanocytes. These data suggest that the 94,000-dalton glycoprotein is an oncofetal antigen of ectodermal origin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267607      PMCID: PMC319667          DOI: 10.1073/pnas.78.6.3834

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Foetal-associated material: its expression in long-term cultured human skin.

Authors:  M G Lewis; G Rowden; K M Sheikh
Journal:  Differentiation       Date:  1975-08-11       Impact factor: 3.880

2.  A nonselective analysis of SV40 transformation of mouse 3T3 cells.

Authors:  R Risser; R Pollack
Journal:  Virology       Date:  1974-06       Impact factor: 3.616

3.  Cell surface glycolipid and glycoprotein glycosyltransferases of normal and transformed cells.

Authors:  L M Patt; W J Grimes
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

4.  The indentification of foetal antigens in human bone marrow cells.

Authors:  M G Lewis; K M Sheikh; P Avis; V M Whitehead; C Vera
Journal:  Differentiation       Date:  1974-10       Impact factor: 3.880

5.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

6.  Monoclonal antibodies to human melanoma-associated antigens.

Authors:  K Imai; G A Molinaro; S Ferrone
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

7.  Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.

Authors:  D R Galloway; R P McCabe; M A Pellegrino; S Ferrone; R A Reisfeld
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

8.  Human melanoma-associated antigens: role of carbohydrate in shedding and cell surface expression.

Authors:  A C Morgan; D R Galloway; K Imai; R A Reisfeld
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms.

Authors:  R G Woodbury; J P Brown; M Y Yeh; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

10.  Human melanoma associated antigens: a solid-phase assay for detection of specific antibody.

Authors:  A C Morgan; D R Galloway; B S Wilson; R A Reisfeld
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

View more
  3 in total

1.  Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.

Authors:  C W Vogel; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

2.  National Pancreatic Cancer Project. Workshop on pancreatic tumor markers.

Authors:  H Z Kupchik; R A Reisfeld; V L Go
Journal:  Dig Dis Sci       Date:  1982-01       Impact factor: 3.199

3.  Human polyomaviruses in skin diseases.

Authors:  Ugo Moens; Maria Ludvigsen; Marijke Van Ghelue
Journal:  Patholog Res Int       Date:  2011-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.